Le Lézard
Classified in: Health
Subjects: NPT, DIS, DEI

Council of Autism Service Providers Announces Public Comment for the Applied Behavior Analysis Accreditation Program Draft Standards


WAKEFIELD, Mass., March 22, 2022 /PRNewswire-PRWeb/ -- The Council of Autism Service Providers (CASP) announced today that it is soliciting feedback on the Applied Behavior Analysis Accreditation Program Draft Standards (version 1.0). In the future, the Standards will be overseen by a nonprofit accreditation agency. The public comment period will run from March 22 to April 15, 2022.

Individuals and organizations who are interested in reviewing and commenting on the Standards, click http://www.casproviders.org/acq-public-comment. In total there are 55 standards in eight sections addressing: business operations, human resources, clinical personnel, clinical operations, financial operations, quality management, patient protections and risk management.

"The Standards Committee is made up of dedicated experts in the field of ABA, who have carefully vetted each standard over the past eight months. We are excited to share this draft with the public for their feedback as part of our commitment to be transparent and inclusive," notes Eric Larsson Ph.D. LP BCBA-D, Chair of the Standards Committee and Executive Director of Clinical Services at Lovaas Institute Midwest. "As part of the final drafting process, we want to make sure the standards are covering the appropriate topics and are properly calibrated to promote quality-based care to individuals and their families negatively impacted by autism."

"CASP is asking interested parties to provide feedback through an online survey form and direct comments," adds Erick Dubuque, Ph.D., BCBA-D, LBA (KY), CASP's Vice President of Accreditation. "The Standards Committee members have carefully identified, vetted and prioritized the standards with a focus on protecting patients and improving clinical outcomes."

"Serving on the Standards Committee has been a very rewarding experience. It has showcased many of the current challenges and opportunities associated with ABA services," says Kristie Thompson, Ph.D., LP (NC, VA), BCBA-D, Standards Committee Member and Clinical Program Manager for the National ABA Team at Optum. "For the last 9 months, our Committee has engaged in dynamic conversations addressing key issues related to quality services. I am confident that ACQ is taking an important first step with its new accreditation program to promote best practices in the field."

The Standards Committee will continue to meet during the public comment period to review the feedback provided outside parties. If interested in learning more about the Autism Commission on Quality, call (803) 520-6164 or see http://www.casproviders.org.

The Council of Autism Service Providers is a non-profit association of for-profit and not-for-profit agencies serving individuals with autism spectrum disorders. Our member agencies care for more than 80,000 children and adults with autism across the United States and have collective revenues approaching 1 billion dollars. CASP represents the autism provider community to the nation at large including government, payers, and the general public. We serve as a force for change, providing information and education and promoting standards that enhance quality. More information is available at http://www.casproviders.org.

Media Contact

Erick Dubuque, CASP, (803) 520-6164, [email protected]

 

SOURCE CASP


These press releases may also interest you

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 19:30
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...



News published on and distributed by: